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Abstract 
Parkinson’s disease (PD) patients show pronounced slowing of resting-state oscillatory brain 
activity compared to healthy controls. In addition, repetitive transcranial magnetic stimulation 
(rTMS) has shown to have possible therapeutic effects on motor symptoms of PD. However, 
the precise electrophysiological mechanisms behind these effects are unknown. In this cross-
over, sham-controlled study, 15 off-drugs PD patients underwent two sessions where active 
or sham high-frequency rTMS at 10 Hz was performed on the primary motor cortex (M1). 
Active rTMS, improved overall motor performance and induced an increase of oscillatory 
activity with a shift of EEG low α peak towards higher frequencies 30 minutes after active 
brain stimulation. The pattern of brain rhythm modulations suggests that 10 Hz rTMS over 
M1 seems to be able to act on the thalamo-cortical resonance interplay entraining neural 
oscillations at the same frequency, in association with a clinical improvement of motor 
performance in PD.  
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Introduction 
The abnormal synchronization and alteration in neural network oscillations between 
cortical and deep brain structures underlies the pathophysiology of various brain disorders 
including Parkinson’s disease (PD) [1-6]. In particular, it has been demonstrated that 
moderately advanced, non-demented PD patients show pronounced slowing of resting-state 
oscillatory brain activity compared to healthy controls, consisting of a widespread increase in 
θ and low α relative power values with a slight change in the cortical distribution of high α 
power [7]. 
Transcranial magnetic stimulation (TMS), with rapidly oscillating magnetic fields 
administered by a coil positioned on the scalp, allows non-invasive stimulation of the human 
brain [8]. It is well documented that repetitive TMS (rTMS) protocols do not pose significant 
risks in the general population or PD patients [9, 10]. Moreover, rTMS has proved to have a 
therapeutic role improving symptoms of various neurological and psychiatric disorders [11-
14]. Of all the movement disorders, PD has received the most attention with regard to rTMS 
therapeutic studies [11]. Several studies have indicated that patients with PD have cortical 
dysfunction [15]. An extensive evidence based synthesis of established and potential 
therapeutic applications of rTMS in the neurological and psychiatric domains [12] gave a 
recommendation of possible efficacy for the effect of high-frequency rTMS (5–25 Hz) of 
bilateral (multiple) M1 areas on motor symptoms of PD but no recommendation for low-
frequency or high-frequency rTMS of unilateral M1 representation of the hand. However, 
where no recommendation has been proposed, the absence of evidence should not be taken as 
evidence for the absence of effect. This is especially true for treatments with very variable 
individual responses, such as rTMS [12]. 
rTMS can be used in basic research to study how perturbations in activity in a focal 
brain area affect the neural network oscillations [16, 17], demonstrating that it can interact 
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with spontaneous oscillatory rhythms existing in the cortical circuits activated by the 
stimulation [18-22]. This may induce an activity-dependent modulation according to phase-
locking synchrony between cortical oscillations and the pattern of the stimulation [20]. 
Interestingly, the modification of cortical oscillatory activity through the use of rhythmic 
repetitive stimulation [23, 24] may readjust pathological patterns of brain activity. This would 
allow an opportunity to induce new oscillatory patterns, which could adequately modulate the 
neural response of a network (i.e., entrainment) [25]. Modulating these rhythms may be a 
valuable therapeutic approach, optimally designed in closed-loop stimulation techniques [26]. 
It is also tempting to consider that the frequency- and pattern dependent therapeutic effects of 
rTMS could come, at least in part, from an interaction with some altered oscillations 
involving cortical networks [20]. 
The general purpose of this electrophysiological study was to enhance the 
understanding of the probable electrophysiological mechanism underlying the therapeutic 
effects of rTMS in PD patients. To achieve this, the effect of rTMS induced modulation of 
oscillatory activity was compared with the alteration of oscillations in PD. The hypothesis 
that, in PD patients at rest, a transient effect of modulation of alpha band oscillations (8-12 
Hz) can be externally entrained by the 10 Hz frequency of rTMS used was tested. The 
resolution of this matter is of considerable interest because it may suggest new ways to use 
combined EEG/TMS techniques as both a diagnostic test and therapeutic tool to restore 
proper neural oscillations in PD. To address this issue, we used surface EEG to quantify the 
cortical oscillatory activity pre- and post-rTMS over M1. 
Several lines of evidence support the use of the aforementioned frequency of rTMS in 
the current study. Firstly, reviews of clinical trials which have assessed the therapeutic effects 
of rTMS in PD, have demonstrated stronger beneficial effects of high-frequency as compared 
with low-frequency rTMS over M1 on motor symptoms in PD patients [11, 12, 27]. 
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Furthermore, a series of studies using positron emission tomography (PET) provide evidence 
that short trains of 10 Hz rTMS can stimulate subcortical dopamine release in the striatum 
(specifically, the caudate nucleus and putamen) in healthy subjects and PD patients [28-31]. 
Additionally, the release of dopamine in the putamen was greater in the more affected 
hemisphere in mild hemiparkinsonian patients [29]. Thus it has been demonstrated that 10 Hz 
rTMS can act indirectly on the subcortical level via stimulation at connected cortical areas 
[29]. Lastly, it has been proposed that high-frequency stimulation has sufficiently short time 
intervals between pulses to build up a large “summation” of neural activity, which 
consequently results in greater recruitment and activation of cortico-thalamic descending 
pathways [20, 22]. Overall high-frequency rTMS at 10 Hz seems to have the potential to act 
on the abnormal processing in the cortico–basal ganglial loops which underlies PD causes 
[11]. 
 
Results 
No adverse side effects of rTMS were reported by any of the participants during all 
experimental conditions. The results of the two interventions (10 Hz rTMS or sham rTMS) 
are shown by Figure 1 for clinical scores and by Figure 2 for relative power which reflected 
the regional oscillatory activity of neural assemblies. 
Clinical motor performance   
There was a significant main effect of ‘Time of evaluation’ with F(1,14) = 22.9, p < 
0.001 ηp2 = .62, which seems to suggest an overall decrease of motor subscale of UPRS 
score after each of rTMS interventions as compared with the motor evaluation before each 
the rTMS session (14.0 vs. 10.5). Interestingly, there was a significant two-way interaction 
‘rTMS condition’ by ‘Time of evaluation’ with F(1,14) =37.7, p < 0.001 ηp2 =.73. Post-hoc 
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comparisons for the significant interaction showed that both rTMS conditions improved 
overall motor performance. In particular active rTMS was associated with an improvement of 
motor response of 35.4% (13.93 vs. 9.00, p <.001) and sham rTMS orived motor 
performance by 14.6% (14.13 vs. 12.07, p <.01). However active rTMS improved overall 
motor performance significantly more than sham rTMS 35 minutes post-stimulation (9.00 vs. 
12.07, p <.01, Bonferroni corrected). Figure 1 shows total UPDRS III score pre- and post- 
rTMS interventions. 
< Figure 1 about here >  
Relative power α (8.00-12.75 Hz) frequency band  
Table 2 summarise ANOVA statistical results of relative EEG power for frontal, 
central, parietal and occipital electrodes at α (8.00-12.75 Hz) frequency band. 
< Table 2 about here >  
 
A significant variation among the rTMS conditions was found in fronto-central electrode 
sites but reached statistical significance at central electrodes site only. First, it was 
checked if there was a significant difference in the pre-stimulation period comparing 
active vs. sham conditions for the entire α frequency band of interest. There were no 
significant differences in pre-stimulation period between the two interventions for central 
electrodes site. Post-hoc comparisons for the significant interaction ‘rTMS condition’ x 
‘Time of evaluation’ x ’frequency bin’ revealed that for active rTMS condition and 
frequency bin 9.00-9.75 Hz, there was a significant difference with an increase of 
regional oscillatory activity comparing the relative power values pre-stimulation and post-
stimulation with whose obtained 30 minutes after the end of active rTMS intervention 
(7.0 and 7.2 vs. 10.5 %, p <.05, Bonferroni corrected). No other significant modulation of 
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cortical oscillations was observed, particularly following sham rTMS. Thus, as shown in 
Figure 2, active rTMS, but not ‘sham’ stimulation, induced a modulation of oscillatory 
activity with a shift of dominant frequency α peak towards higher frequencies at central 
electrodes site. No other frequency bands were significantly affected by the experimental 
manipulations. 
< Figure 2 about here > 
Discussion 
The general purpose of this study was to gain new insight into a probable 
electrophysiological mechanism underlying the possible therapeutic effects of rTMS in PD 
patients. In particular, we aimed to evaluate if brain stimulation with TMS may readjust 
pathological patterns of brain oscillatory activity which is alterated in PD patients [7, 32]. 
The main finding of the current study was that excitatory rTMS at 10 Hz induced a specific 
increase of amplitude in low-α relative power with a shift of the dominant α frequency 
towards higher frequencies in PD patients 30 minutes post stimulation. This direct 
electrophysiological modulation of cortical oscillatory activity was concomitant with the 
improvement in clinical motor symptoms observed in the same group of patients.  
Data published to date suggest possible antiparkinsonian effects of non-invasive 
rTMS on motor symptoms, especially when applied at high-frequency on large M1 regions of 
both hemispheres. The majority of studies show global improvement of motor part of 
UPDRS, especially of movement speed or gait velocity, following the focal stimulation of 
hand representation [12]. In particular, a small number of single session, proof-of-principle 
studies have shown a 10–30% improvement of clinical motor symptoms of active rTMS, with 
no effects after sham stimulation [11]. The improvement of motor performance of the current 
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study was 20.8% greater in the case of active rTMS as compared to sham rTMS of the motor 
cortex in PD. This is consistent with the findings of previous clinical trials.  
A number of investigations have demonstrated that the rhythmic aspects of non-
invasive transcranial magnetic stimulation over M1 can induce a modification of cortical 
oscillatory activity [18-22]. In particular, high-frequency stimulation (>5Hz) leads to an 
immediate synchronization of EEG activity with an increase of power particularly in the α 
band, consistent with entrainment of oscillatory activity [21, 22]. Additionally, this work 
shows direct evidence for causal entrainment of brain oscillations by rTMS using concurrent 
EEG in PD. In the current study, the rTMS aftereffects significantly emerged after 30 minutes 
from the end of the trains of stimulation. Recently, it has been postulated [33] that some 
molecular mechanisms can explain the slow building up of rTMS-induced after-effects 
(generally 5–10 min) in humans [34, 35]. Research investigating the pathophysiology of PD 
mostly focuses on basal ganglia dysfunction. However, the main output from the basal 
ganglia is via the thalamus, and corticothalamic feedback constitutes the primary source of 
synapses in the thalamus [4]. We therefore focused on the thalamocortical interplay to 
explain the results of the current proof-of-principle study.  
A pathophysiological framework of alternation of brain oscillations in common for 
PD, neurogenic pain, epilepsy, tinnitus and major depression has been proposed by Rodolfo 
Llinas [3] and called Thalamocortical dysrhythmia (TCD). In TCD phenomenon, bursting 
thalamic relay neurons exert a rhythmic influence on thalamocortical modules in the θ 
frequency band [36]. This will disrupt  the normal, state-dependent, flow of information 
between thalamus and cortex [37], leading to disturbances of sensation, motor performance 
and cognition. The existence of TCD has been demonstrated by a series of 
Magnetoencephalography (MEG), EEG and single cell physiology studies in patients a rest 
[2-6]. The pathophysiological framework of TCD has been adopted to explain the genesis of 
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parkinsonian symptoms [4]. In a ground breaking study by Sarnthein and Jeanmonod [4], 
during the surgical intervention in PD patients, local field potentials (LFPs) were recorded 
from pallidal-recipient thalamic nuclei VLa and VA. Simultaneously, EEG was recorded 
from several sites on the scalp. The highest thalamocortical coherence was found in the θ 
frequency band (4 –9 Hz) with a mean peak frequency of 7.5 Hz. The functional coupling 
between the thalamus and cortex was confirmed by the high θ coherence between the two 
which reached 70% and was maximal with frontal scalp sites on both hemispheres. The high 
thalamocortical coherence underlines the importance of thalamic function for the genesis of 
scalp EEG [4]. 
Overall, the current electrophysiological results suggest that targeting the specific 
cortical areas in the most affected hemisphere by brain stimulation could affect the cortical 
dysfunction in PD directly, or could modify activity in the basal ganglia networks that are 
corticostriatal and cortico subthalamic projections [38]. Indeed, the rTMS 10 Hz in the 
present study appears to be able to modulate the rhythmic thalamocortical interplay by 
entraining the resonance between the thalamus and cortex at ~ 10 Hz thus generating a state 
that seems to restore proper neural oscillations in association with a clinical improvement of 
motor performance in PD. Such improvement could be related to an increase in dopamine 
release, although the slight improvement of motor symptoms after sham rTMS also suggest 
the possibility of a partial intervention of placebo effects in PD as in previous studies [29, 
39]. Nevertheless, after controlling for the placebo or auditory effects with sham rTMS 
condition, we were able to demonstrated that active rTMS was able to act on internally 
generated and persistent thalamic frequency range activity and served as a trigger to 
temporally re-establish proper thalamo-cortical resonance oscillatory network function, with 
a consequent increased α rhythmicity in PD patients at rest 30 minutes post stimulation. 
These results support the hypothesis that electrical brain stimulation like TMS can trigger an 
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oscillation and reset the ongoing rhythmic activity of a local thalamic pacemaker [20, 28, 40]. 
Once oscillators are reset, regionally-specific endogenous rhythms of the brain may 
reemerge, and through this mechanism restores normal brain function [41]). Thus, the cortical 
targets of non-invasive brain stimulation might be conceptualised as ‘entry ports’ for 
modulation of activity in specific bihemispheric, cortico subcortical neural networks [38].  
Some limitations of the current study should be mentioned. First, given that our 
sample size was relatively small, findings reported here should be reproduced in larger 
cohorts before firm conclusions can be drawn. Second, the study employed a within-subject 
design so did not have a real sham/control group. Third, because of the lack of a control 
stimulation condition (i.e. different stimulation frequency) nonspecific effects of the 
stimulation cannot be ruled out.  
In conclusion, the results of present investigation pointed to the potential of rTMS as 
therapeutic tool to reverse the pathological slowing of oscillatory brain activity observed of 
Parkinson’s disease. This investigation provides an insight into the mechanisms underlining 
the possible therapeutic effects of rTMS and can lead to sensitive treatment efficacy measures 
based on indexes of EEG oscillations; examining the effects of rTMS within the framework 
of dysrhythmic thalamocortical interplay [20]. Future work should look at changes of multi-
band EEG power across various brain regions and advanced data analysis methods could be 
employed to provide comprehensive evidences. Future studies, recoding the EEG signal from 
an increased number of electrodes as compared to the current investigation, would allow 
accurate source location analysis in order to link the brain oscillation effect to thalamo-cortical 
loop. Future applied clinical research can attempt to further develop therapeutic strategies to 
restore of normal oscillatory patterns which is associated with effective treatment of PD. 
Specifically, to conduct multiple stimulation sessions (e.g., one session per day for a week) 
and then examine the clinical improvements and neural changes. 
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Materials and methods 
Subjects 
In this cross-over, sham-controlled study a total of 16 patients were initially recruited. 
However, one patient was excluded in the absence to obtain a reliable determination of the 
rest motor threshold. Thus, fifteen patients (age 45-80 years) with idiopathic Parkinson’s 
disease (disease duration 2–13 years) were included in this study. Level of cognitive 
impairment was determined using the mini–mental state examination (MMSE) [42]. Disease 
duration was based on the patients’ subjective estimate of the time of occurrence of the first 
motor symptoms. Side of onset was based on the body-half in which these symptoms first 
occurred. Unified Parkinson’s disease Rating Scale motor scores (UPDRS-III) [43] and 
modified Hoehn and Yahr stages [44] were obtained 12 hours after an overnight withdrawal 
of anti-parkinsonian medication, i.e. in ‘off-drug’ state by a trained physician prior to and 
after rTMS sessions. Subject characteristics are listed in Table 1. Written informed consent 
was obtained from all participants and Ethics approval was provided by the regional Medical 
School Ethics Committee of Verona University, Italy. Ethics review criteria conformed to the 
Helsinki declaration.  
< Table 1 about here >  
Experimental paradigm 
Subjects were tested in a quiet and dimly light room. First, motor performance was 
assessed clinically, and then they were seated in a comfortable armchair at rest and awake 
state. Second, the EEG cap was mounted and the impedance check completed. Third, TMS 
parameter of the motor threshold at rest was measured (See below). Fourth, patients were 
instructed to close their eyes and remain awake for two minutes immediately before, 
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immediately after and until 30 minutes after the end of rTMS delivery. PD patients were 
asked to keep their eyes closed during the EEG recordings to maximize occipital alpha 
oscillations and its influence on thalamo-cortical circuit as in previous studies [3, 45]. One of 
the two interventions, i.e. active rTMS or sham rTMS at 10 Hz (see below) was performed on 
the hand motor area of the primary motor cortex (M1) contralateral to the most affected body 
side while the EEG activity was recorded continuously. The EEG cap from the PD patients 
was removed after 30 minutes post rTMS intervention. Thirty-five minutes after the end of 
the rTMS intervention, a clinician performed the motor evaluation with UPDRS-III again. 
The order of the two rTMS sessions was randomised across patients, and each session was 
separated by 48 hours in order to minimise carry-over effects. The duration of rTMS effects 
on motor symptoms is considered to outlast less than one hour after a single rTMS 
intervention (Edwards et al., 2008). Patients were naive to rTMS prior to the study and were 
unfamiliar with the differences between sham and active rTMS regarding its acoustic and 
tactile artifacts. Twenty intermittent trains of 40 pulses (800 stimuli), were delivered for each 
of the two rTMS conditions at 10 Hz and intensities of 90% of individual resting motor 
threshold (RMT). The duration of each train was of 4 seconds and the intertrain interval (ITI) 
was 30 seconds. The total duration rTMS was 10 minutes. 
Transcranial magnetic stimulation 
TMS was performed using a high-power Magstim-Rapid stimulator (Magstim, 
Whitland, UK).The rTMS was applied over the left or right primary motor cortex (M1) (in 
the proximity of the C3 or C4 electrode) simultaneously with EEG data collection. TMS was 
delivered through a figure-of-eight coil (70 mm standard coil; Magstim), oriented so that the 
induced electric current flowed in a posterior–anterior direction over the underlying motor 
cortex. The coil was placed tangentially to the scalp with the handle pointing backward and 
laterally at a 45° angle away from the midline perpendicular to the line of the central sulcus 
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to achieve the lowest motor threshold. A sham rTMS condition was carried out to control for 
the air and bone-conducted auditory stimuli that could contaminate EEG oscillations in the 
target motor system. The sham rTMS condition was performed with the coil tilted at 90˚ to 
the skull in order to avoid real stimulation of the motor cortex.  
Motor Evoked Potentials (MEPs) were recorded from the left or right thenar eminence 
(TE) muscle using Ag/AgCl surface electrodes in a bellytendon montage. The amplified and 
bandpass-filtered (50 Hz–5 kHz) EMG signal was fed into a Micromed Machine (Micromed, 
Treviso, Italy). The optimal position for right TE activation was determined by moving the 
coil in 0.5-cm steps around the motor hand area of the left or right motor cortex of the most 
affected hemisphere. The optimal position was defined as the site where stimuli of slightly 
suprathreshold intensity consistently produced the largest MEPs with the steepest negative 
slope in the target muscle (referred to as "motor hot spot"). The intensity of rTMS in all two 
conditions was set to 90% of individual RMT. The motor threshold, which reflects the global 
excitability of the corticospinal motor pathway, has been defined as the intensity of TMS that 
produces an identifiable MEP of ~50 µV in at least five out of ten TMS pulses [46]. 
Electroencephalographic acquisition and analysis 
Continuous EEG was recorded with a MR compatible EEG amplifier (SD MRI 32, 
Micromed, Treviso, Italy). The EEG signal was recorded from 19 Ag/AgCl electrodes sites. 
Electrode montage and placement was according to the International 10–20 system. 
According to the 10-20 system, the reference electrode was at AFz site, whereas the ground 
electrode was at FCz site as in previous studies using the same system [21, 28]. The 
impedance was kept below 10 kΩ. The activities in the right TE muscle and in the right eye 
vertical electroculogram (vEOG) were bipolarly registered from two surface electrodes in 
two EMG channels. To ensure the subjects’ safety, the wires were carefully arranged to avoid 
loops and physical contact with the subject. To avoid electrical saturation of EEG channels 
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induced by TMS, the EEG amplifier had a resolution of 22 bits with a range of ± 25.6 mV. 
An anti-aliasing hardware band-pass filter was applied with a bandwidth between 0.15 and 
269.5 Hz. EEG data were sampled at a frequency of 1024 Hz using the software package 
SystemPlus (Micromed, Treviso, Italy).  
A re-reference off-line was obtained by the application of reference electrode 
standardisation technique (REST) in the study of EEG default mode network [47]. The EEG 
data were processed off-line using commercial software (Vision Analyser, Brain Vision, 
Munich, Germany). To demonstrate the rTMS effect on modulation of EEG oscillations, the 
following four pairs of homologous electrodes across hemispheres were selected for analyses: 
F3/F4, C3/C4, P3/P4 and O1/O2. The 120 seconds immediately before, immediately after, 
and 30 minutes after each 10 minutes brain stimulation of 20 intermittent trains of rTMS 
were considered for analysis. Two minutes of continuous data were divided into thirty 
consecutive, non-overlapping epochs of 4,096 data points. Subsequently, the data were 
digitally filtered with a band-pass of 1–46 Hz. Epochs with eye movements and muscle or 
movement artefacts (as indicated by HEOG activity exceeding ±40 µV and activity at other 
electrodes exceeding ±70 µV) were excluded. This resulted in the exclusion of ~7 epochs per 
rTMS condition (23% rejection rate). A discrete Fast Fourier Transform (FFT) of the 
remaining epochs with a resolution of 0.25 Hz was computed for all electrodes and then 
averaged. Non-overlapping hamming-windows controlled spectral leakage. The FFT power 
value measurements within each frequency between 2.0 and 45.75 Hz were averaged to 
create 44 non-overlapping < 1 Hz frequency bins. The relative power (which reduces the 
effect of inter-subject variation in absolute power) at each frequency bin was measured, by 
taking the absolute power at each bin divided by the sum of absolute power of all frequency 
bins over the entire frequency range (2.0-45.75 Hz) as in a previous study [32]. Using relative 
power rather than absolute power results in a lower variance of power values within subject 
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groups [7]. The α frequency band (8.00-12.75 Hz) of interest was chosen for statistical 
analyses and contained 5 frequency bins.  
Statistical analyses 
Data were analysed using SPSS for Windows version 20. First, we examined the 
effects of rTMS protocol on the overall motor performance in PD patients. Thus, a total score 
of the motor subscale of UPDRS was submitted to a repeated measures ANOVA with the 
factors: “rTMS condition” (Active rTMS and sham rTMS); and “Time of evaluation” (pre-
stimulation, post-stimulation and 35 minutes post-stimulation). Second, to assess whether the 
rTMS artificially induced modulation of neural oscillations in the α frequency range in eyes-
closed resting state, mean relative power values were submitted to four separate repeated 
measures ANOVA for frontal (F3/F4), central (C3/C4), parietal (P3/P4) and occipital 
(O1/O2) pairs of electrodes. Each ANOVA had the factors: “rTMS condition” (Active rTMS 
and sham rTMS); “Time of evaluation” (pre-stimulation, post-stimulation, and 30 minutes 
post-stimulation); and frequency bin (8.00-8.75, 9.00-9.75, 10-10.75, 11.00-11.75 and 12.00-
12.75 Hz). For each ANOVA, the sphericity assumption was assessed with Mauchly’s test. 
Greenhouse-Geisser epsilon adjustments for non-sphericity were applied where appropriate. 
Post-hoc paired t-test adjusted for multiple comparisons with Bonferroni method was used. 
For all statistical tests, p < .05 was considered significant. 
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Figures and tables legends 
 
Table 1: Subject characteristics 
 
Table 2: ANOVA statistical results of relative EEG power for frontal, central, parietal and 
occipital electrodes at α (8.00-12.75 Hz) frequency band 
 
Figure 1: Total UPDRS III score before and after each type of rTMS intervention. Values are 
presented as mean (±SEM). Active rTMS improved overall motor performance 35 minutes 
post stimulation relative to Sham rTMS. ** p < .01; Bonferroni corrected. 
 
Figure 2: Superimposition of mean (±SEM) relative power transformation from 2 to 29.75 
Hz averaged over central electrodes. Active rTMS at 10 Hz, but not ‘sham’ stimulation, 
induced a power increase 30 minutes post brain stimulation within the α (8.00-12.75 Hz) 
frequency with a shift of dominant frequency α peak towards higher frequencies. * p < .05; 
Bonferroni corrected.  
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Table 1. Subject characteristics 
 Parkinson ‘s 
disease patients 
(N=15) 
Age (years, mean ±SD) 64.1 ± 12.6  
Gender (♂/♀) 13/2 
MMSE (mean ±SD) 27.7 ± 2.8 
Side of onset (left/right) 9/6 
Disease duration (years, mean ±SD) 4.9 ± 3.4 
H and Y modified  “OFF” (1/1.5/2/2.5/3) 2/5/4/1/3 
UPRS-III  “OFF”(mean ±SD)  14.0 ± 6.5 
Stimulation side (left/right) 8/7 
MMSE= The Mini Mental State Examination, H and Y modified=modified version of the 
Hoehn and Yahr rating scale, UPDRS-III=motor part of the Unified Parkinson's Disease 
Rating Scale. 
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Table 2. ANOVA statistical results of relative EEG power for frontal, central, parietal and 
occipital electrodes at α (8.00-12.75 Hz) frequency band. 
Effect 
 
Frontal Central Parietal Occipital 
Time  
 
F(2,28)=4.3, *, 
η2p = .24 
F(2,28)=1.4, p = 
ns, η2p = .09 
F(2,28)=5.3, *, 
η2p = .27 
F(2,28)=2.3, *, 
η2p = .14 
rTMS condition 
 
F(1,14)=0.0, p = 
ns, η2p = .00 
F(1,14)=0.2, p = 
ns, η2p = .02 
F(1,14)=0.2, p = 
ns, η2p = .01 
F(1,14)=0.0, p = 
ns, η2p = .00 
Frequency bin 
 
F(1.7,24.5)=6.9, 
**, η2p = .33 
F(1.7,23.6)=5.8, 
*, η2p = .29 
F(2.0,28.2)=4.3, 
*, η2p = .23 
F(1.8,25.9)=6.0, 
**, η2p = .30 
Time *  rTMS 
condition 
F(1.2,16.5)=0.1, 
p = ns, η2p = .01 
F(1.2,17.2)=0.1, 
p = ns, η2p = .01 
F(2,28)=0.1, p = 
ns, η2p = .01 
F(1.2,16.6)=0.0, 
p = ns, η2p = .00 
Time *  
frequency bin 
F(3.4,48.4)=2.8, 
*, η2p = .16 
F(3.5,48.8)=1.4, 
p = ns, η2p = .09 
F(3.6,51.0)=1.4, 
p = ns, η2p = .09 
F(4.1,57.9)=3.1, 
*, η2p = .18 
Condition * 
Frequency bin 
F(2.3,32.3)=0.5, 
p = ns, η2p = .04 
F(2.0,28.5)=0.5, 
p = ns, η2p = .03 
F(4,56)=0.1, p = 
ns, η2p = .00 
F(2.5,35.6)=0.2, 
p = ns, η2p = .02 
Time * rTMS 
condition * 
frequency bin 
F(3.1,42.8)=0.5, 
p = ns, η2p = .07 
F(2.7,38.1)=3.4, 
*, η2p = .20 
F(4.3,60.8)=2.1, 
p = ns, η2p = .13 
F(3.1,43.9)=0.8, 
p = ns, η2p = .05 
ns — non-significant. Significant main effect of TMS condition is indicated in bold.  
* p<.05, ** p<.01. 
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Figure 1. 
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Figure 2. 
 
